252 related articles for article (PubMed ID: 18990542)
1. [Clinically non functioning pituitary adenomas and gonadotroph-cell adenomas].
Caron P
Presse Med; 2009 Jan; 38(1):103-6. PubMed ID: 18990542
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
3. [Gonadotroph pituitary adenomas].
Chanson P
Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
[TBL] [Abstract][Full Text] [Related]
4. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
5. Non-functioning pituitary adenomas.
Chanson P; Brochier S
J Endocrinol Invest; 2005; 28(11 Suppl International):93-9. PubMed ID: 16625856
[TBL] [Abstract][Full Text] [Related]
6. Clinically non-functioning pituitary adenoma.
Jaffe CA
Pituitary; 2006; 9(4):317-21. PubMed ID: 17082898
[TBL] [Abstract][Full Text] [Related]
7. Recognition of gonadotroph adenomas in women.
Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
[TBL] [Abstract][Full Text] [Related]
8. Pituitary incidentaloma: to operate or not to operate?
Donckier JE; Gustin T
Acta Chir Belg; 2012; 112(4):255-60. PubMed ID: 23008988
[TBL] [Abstract][Full Text] [Related]
9. Functional pituitary gonadotroph adenoma in male patients: Case report.
Ram N; Khan SA; Das B; Islam N
J Pak Med Assoc; 2022 Aug; 72(8):1652-1655. PubMed ID: 36280939
[TBL] [Abstract][Full Text] [Related]
10. Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases.
Young WF; Scheithauer BW; Kovacs KT; Horvath E; Davis DH; Randall RV
Mayo Clin Proc; 1996 Jul; 71(7):649-56. PubMed ID: 8656706
[TBL] [Abstract][Full Text] [Related]
11. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and outcome of pituitary adenomas in teenagers.
Cannavò S; Venturino M; Curtò L; De Menis E; D'Arrigo C; Tita P; Billeci D; Trimarchi F
Clin Endocrinol (Oxf); 2003 Apr; 58(4):519-27. PubMed ID: 12641637
[TBL] [Abstract][Full Text] [Related]
13. The use of beta-subunits of gonadotrophin hormones in the follow-up of clinically non-functioning pituitary tumours.
Greenman Y; Tordjman K; Sömjen D; Reider-Groswasser I; Kohen F; Ouaknine G; Stern N
Clin Endocrinol (Oxf); 1998 Aug; 49(2):185-90. PubMed ID: 9828905
[TBL] [Abstract][Full Text] [Related]
14. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study.
Feldkamp J; Santen R; Harms E; Aulich A; Mödder U; Scherbaum WA
Clin Endocrinol (Oxf); 1999 Jul; 51(1):109-13. PubMed ID: 10469480
[TBL] [Abstract][Full Text] [Related]
15. Is Positive Staining of Non-Functioning Pituitary Adenomas for Luteinizing Hormone Associated with a Poor Prognosis?
Diri H; Ozaslan E; Kurtsoy A; Tucer B; Simsek Y; Ozturk F; Durak AC; Erten S; Bayram F
Turk Neurosurg; 2017; 27(1):8-13. PubMed ID: 27593756
[TBL] [Abstract][Full Text] [Related]
16. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma.
Shimon I; Rubinek T; Bar-Hava I; Nass D; Hadani M; Amsterdam A; Harel G
J Clin Endocrinol Metab; 2001 Aug; 86(8):3635-40. PubMed ID: 11502789
[TBL] [Abstract][Full Text] [Related]
17. Pituitary tumours: pituitary incidentalomas.
Molitch ME
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):667-75. PubMed ID: 19945030
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
19. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
20. Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.
Reznik Y; Chapon F; Lahlou N; Deboucher N; Mahoudeau J
J Endocrinol Invest; 1997 Oct; 20(9):566-8. PubMed ID: 9413812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
